NCT06445322 - Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 20, 2024

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2030

Conditions

Stargardt DiseaseStargardt Disease 1Cone Rod DystrophyJuvenile Macular Degeneration

Interventions

DIAGNOSTIC_TEST

Prescreening Assessments

Various genetic and visual assessments.

Trial Locations (8)

RECRUITING

Wilmer Eye Institute at John Hopkins, Baltimore

RECRUITING

Vitreo Retinal Associates, Gainesville

RECRUITING

Cincinnati Eye Institute, Cincinnati

RECRUITING

University of Michigan Kellogg Eye Center, Ann Arbor

RECRUITING

Retina Foundation of Texas, Dallas

RECRUITING

Retina Consultants of Texas, Houston

RECRUITING

University of San Francisco, San Francisco

RECRUITING

Massachusetts Eye and Ear, Boston